您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > TNIK-IN-3
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
TNIK-IN-3
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
TNIK-IN-3图片
CAS NO:2754265-25-1
包装与价格:
包装价格(元)
1 mg电议
5 mg电议
10 mg电议
25 mg电议
50 mg电议
100 mg电议
1 mL*10 mM(in DMSO)电议

产品介绍
TNIK-IN-3 是一种有效,选择性和具有口服活性的TNIK激酶抑制剂,IC50值为 0.026 μM。TNIK-IN-3 还可以抑制FLT4(IC50=0.030 μM),FLT1(IC50=0.191 μM) 和DRAK1(IC50=0.411 μM)。TNIK-IN-3 具有结直肠癌(CRC)的研究潜力。

产品描述

TNIK-IN-3 is a potent, selective and orally active inhibitor of Traf2- and Nck-interacting protein kinase (TNIK), with an IC 50 of 0.026 μM. TNIK-IN-3 could also inhibit Flt4 ( IC 50 =0.030 μM), Flt1 ( IC 50 =0.191 μM) and DRAK1 ( IC 50 =0.411 μM). TNIK-IN-3 can be used for the colorectal cancer(CRC) research [1].

体外活性

TNIK-IN-3 (compound 21k) inhibits Aurora-A, GCK, and MLK3 with IC 50 s of 0.517 μM, 3.657 μM, and 4.552 μM, respectively [1]. TNIK-IN-3 (0.1-100 μM; 3 days) inhibits the viability of HCT116 and DLD-1 cells, with IC 50 s of 4.26 μM and 8.00 μM, respectively [1]. TNIK-IN-3 (2.5-40 μM; 10 days) dose-dependently inhibits the colony formation of HCT116 and DLD-1 cells [1]. TNIK-IN-3 (5-20 μM; 48 h) inhibits the HCT116 and DLD-1 cell migration[1]. TNIK-IN-3 (5-40 μM; 48 h) dose-dependently inhibits the expression ofLRP5 and LRP6 proteins, Wnt target genes AXIN2 and c-Myc in HCT116 cells [1]. TNIK-IN-3 (5-20 μM; 48 h) significantly suppresses the phosphorylation of JNK1/2 in Hela cells [1]. Cell Viability Assay [1] Cell Line: HCT116 and DLD-1 cells Concentration: 0.1-100 μM Incubation Time: 3 days Result: Inhibited cell viability in a dose-dependent manner. Cell Viability Assay [1] Cell Line: HCT116 cells Concentration: 5, 10, 20, 40 μM Incubation Time: 48 hours Result: Inhibited the expression of Wnt target genes AXIN2 and c-Myc, LRP5 and LRP6 proteins.

体内活性

TNIK-IN-3 (compound 21k) (100-150 mg/kg; p.o. twice daily for 18 days) dose-dependently inhibits tumor growth[1]. Animal Model: Six-week-old female NOD-SCID mice were injected with HCT116 cells [1] Dosage: 100, 150 mg/kg Administration: P.o. twice daily for 18 days Result: Significantly inhibited tumor growth at a dose of 150 mg/kg. No obvious weight loss and no other side effects were observed.

Cas No.

2754265-25-1

分子式

C23H18FN3O2

分子量

387.41

储存和溶解度

DMSO:75.6mg/mL (195.1mM),Need ultrasonic
Powder: -20°C for 3 years
In solvent: -80°C for 2 years